Cargando…
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning
The level of Epstein-Barr virus DNA in blood has proven to be a biomarker with some predictive value in allogeneic hematopoietic stem cell transplantation patients (HSCT). We evaluated the impact of EBV load on survival of 51 patients (32M/19F, median age: 32 years, from < 1 to 68 years old), who...
Autores principales: | Li, Qin, Rane, Lalit, Poiret, Thomas, Zou, Jiezhi, Magalhaes, Isabelle, Ahmed, Raija, Du, Ziming, Vudattu, Nalini, Meng, Qingda, Gustafsson-Jernberg, Åsa, Winiarski, Jacek, Ringdén, Olle, Maeurer, Markus, Remberger, Mats, Ernberg, Ingemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058676/ https://www.ncbi.nlm.nih.gov/pubmed/27102298 http://dx.doi.org/10.18632/oncotarget.8803 |
Ejemplares similares
-
Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
por: Poiret, Thomas, et al.
Publicado: (2014) -
Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
por: Poiret, Thomas, et al.
Publicado: (2018) -
Epstein-Barr virus latency switch in human B-cells: a physico-chemical model
por: Werner, Maria, et al.
Publicado: (2007) -
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
por: Afram, Gabriel, et al.
Publicado: (2018) -
Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018)